Supplementary Figure 2 - In vitro characterization of and therapy study with XE-mIL12. from Antibody-Based Delivery of Cytokine Payloads to Carbonic Anhydrase IX Leads to Cancer Cures in Immunocompetent Tumor-Bearing Mice